Development of cell death-based method for the selectivity screening of caspase-1 inhibitors

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Caspase-1 selective inhibitors show therapeutic potential for inflammatory diseases.
• Current caspase selectivity assays using purified enzymes are costly and time-consuming.
• A need exists for a rapid, reliable cell-based assay for screening caspase inhibitor selectivity.

Purpose of the Study:

• To develop a cell-based assay for screening the selectivity of multiple caspases in a biologically relevant context.
• To evaluate the efficacy of caspase inhibitors in a single assay using DNA fragmentation as a marker of apoptosis.

Main Methods:

• A Jurkat cell line was utilized to examine DNA fragmentation following etoposide induction.
• The assay was performed in the presence or absence of specific inhibitors for caspases 1, 3, 8, 9, and pan-caspase inhibitors.
• DNA fragmentation, a key indicator of apoptosis, was measured to assess inhibitor activity.

Main Results:

• Inhibitors of caspases-3, -8, -9, and pan-caspase significantly inhibited etoposide-induced DNA fragmentation.
• A caspase-1 specific inhibitor did not prevent DNA fragmentation, suggesting non-involvement or absence of caspase-1 family proteases in this process.
• The assay demonstrated that inhibition of caspases 3, 8, and 9 leads to downstream caspase cascade downregulation.

Conclusions:

• The developed cell-based assay allows for the assessment of caspase inhibitor selectivity against a panel of caspases (2, 6, 7, 8, 9, 10).
• This assay provides a more efficient and relevant method for evaluating novel therapeutic agents targeting inflammatory diseases.
• Caspase-1 inhibitors were found to be ineffective in preventing etoposide-induced DNA fragmentation in Jurkat cells.